Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Shenzhen Kangtai Biological Products Co Ltd
Revenue
Shenzhen Kangtai Biological Products Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
|
Revenue
¥3.1B
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Beigene Ltd
HKEX:6160
|
Revenue
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Innovent Biologics Inc
HKEX:1801
|
Revenue
¥6.2B
|
CAGR 3-Years
17%
|
CAGR 5-Years
266%
|
CAGR 10-Years
N/A
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Revenue
¥5.5B
|
CAGR 3-Years
33%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Revenue
¥49.7B
|
CAGR 3-Years
53%
|
CAGR 5-Years
65%
|
CAGR 10-Years
50%
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Revenue
¥1.9B
|
CAGR 3-Years
51%
|
CAGR 5-Years
54%
|
CAGR 10-Years
N/A
|
See Also
What is Shenzhen Kangtai Biological Products Co Ltd's Revenue?
Revenue
3.1B
CNY
Based on the financial report for Sep 30, 2023, Shenzhen Kangtai Biological Products Co Ltd's Revenue amounts to 3.1B CNY.
What is Shenzhen Kangtai Biological Products Co Ltd's Revenue growth rate?
Revenue CAGR 5Y
10%
Over the last year, the Revenue growth was -20%. The average annual Revenue growth rates for Shenzhen Kangtai Biological Products Co Ltd have been 16% over the past three years , 10% over the past five years .